NUREXONE BIOLOGIC INC (NRX.CA) Stock Income Statement
TSX-V:NRX - TSX Venture Exchange - CA67059R1091 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 4.24M | 3.66M | 5.54M | 130.00K | 60.00K | |||
| Research and Development | 1.54M | 1.53M | 1.39M | 0.00 | N/A | |||
| Selling, General, and Administrative Expenses | 2.70M | 2.10M | 4.14M | 130.00K | 60.00K | |||
| Operating Income | -4.24M | -3.66M | -5.54M | -130.00K | -60.00K | |||
| Interest Income/Expense | 7.00K | 18.00K | -550.00K | N/A | 0.00 | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 40.00K | |||
| Non Recurring Items | N/A | 0.00 | -2.08M | N/A | N/A | |||
| Income Before Taxes | -4.23M | -3.64M | -8.17M | -130.00K | -20.00K | |||
| Net Income | -4.23M | -3.64M | -8.17M | -130.00K | -20.00K | |||
| EBITDA | -4.19M | -3.62M | -5.54M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.07 | -0.08 | -0.22 | -0.05 | -0.01 | |||
| Statistics | ||||||||
All data in USD